Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review

July 2020 | 63 pages | ID: T7A810BAB83EN
GlobalData

Abstracts

Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplement, cardiovascular systems, vascular grafts, blood glucose monitoring system, peritoneal dialysis, medical electronic, and digital thermometers. The company’s systems find applications in and interventional therapies performed inside blood vessels and cardiac and vascular surgery. Terumo also operates blood centers for collecting blood and processing for addressing the transfusion requirement of patients. The company operates through subsidiaries and associate companies in Japan, China, Europe, North America, South America, Asia Pacific, the Middle East and Africa. Terumo is headquartered in Tokyo, Japan.

Terumo Corp Key Recent Developments

Jul 16,2020: Terumo expands oncology offerings with Quirem Medical acquisition
Jun 10,2020: TUV Rheinland issue first EU MDR certificate for Terumo
Jun 09,2020: Terumo receives the first certificate EU-MDR
Apr 22,2020: Terumo donates USD 2.4 million in cash and products to support COVID-19 pandemic relief efforts worldwide
Oct 31,2019: Terumo and Kikuna Memorial Hospital to launch AI-tech research to improve PCI procedure

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Terumo Corp - Key Facts
Terumo Corp - Key Employees
Terumo Corp - Key Employee Biographies
Terumo Corp - Major Products and Services
Terumo Corp - History
Terumo Corp - Company Statement
Terumo Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Terumo Corp - Business Description
Business Segment: Blood and Cell Technologies Company
Overview
Performance
Key Stats
Business Segment: Cardiac and Vascular Company
Overview
Performance
Key Stats
Business Segment: General Hospital Company
Overview
Performance
Key Stats
Geographical Segment: Americas
Performance
Geographical Segment: Asia and Others
Performance
Geographical Segment: Europe and Others
Performance
Geographical Segment: Japan
Performance
R&D Overview
Terumo Corp - Corporate Strategy
Terumo Corp - SWOT Analysis
SWOT Analysis - Overview
Terumo Corp - Strengths
Terumo Corp - Weaknesses
Terumo Corp - Opportunities
Terumo Corp - Threats
Terumo Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Terumo Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Terumo Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Terumo Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 16, 2020: Terumo expands oncology offerings with Quirem Medical acquisition
Jun 10, 2020: TUV Rheinland issue first EU MDR certificate for Terumo
Jun 09, 2020: Terumo receives the first certificate EU-MDR
Apr 22, 2020: Terumo donates USD 2.4 million in cash and products to support COVID-19 pandemic relief efforts worldwide
Oct 31, 2019: Terumo and Kikuna Memorial Hospital to launch AI-tech research to improve PCI procedure
Sep 20, 2019: Terumo to increase production capacity for alliance business
Aug 05, 2019: Terumo BCT provides grant to Abrale to help support patients living with blood cancer in Brazil
Jul 08, 2019: Terumo invests 26 Million Euro in new production lines for its Belgian Facility
Jun 14, 2019: Orchestra BioMed licences Virtue SEB to Terumo
May 21, 2019: Terumo appoints EU based Subsidiary's Associate as the Newest Terumo Fellow

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Terumo Corp, Key Facts
Terumo Corp, Key Employees
Terumo Corp, Key Employee Biographies
Terumo Corp, Major Products and Services
Terumo Corp, History
Terumo Corp, Other Locations
Terumo Corp, Subsidiaries
Terumo Corp, Key Competitors
Terumo Corp, Ratios based on current share price
Terumo Corp, Annual Ratios
Terumo Corp, Annual Ratios (Cont...1)
Terumo Corp, Annual Ratios (Cont...2)
Terumo Corp, Interim Ratios
Terumo Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Terumo Corp, Medical Equipment, Deals By Type, 2014 to YTD 2020
Terumo Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Terumo Corp, Performance Chart (2016 - 2020)
Terumo Corp, Ratio Charts
Terumo Corp, Medical Equipment, Deals By Year, 2014 to YTD 2020
Terumo Corp, Medical Equipment, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Biotronik SE & Co KG
Becton Dickinson and Co
Stryker Corp
F. Hoffmann-La Roche Ltd
Abiomed Inc
Edwards Lifesciences Corp
Merit Medical Systems Inc
Jarvik Heart Inc
Medtronic Plc
JMDC Inc
Cook Medical Inc